Useful resources |
Galantamine for vascular cognitive impairment (Cochrane Review) ABSTRACT Background: Vascular dementia is the second most common form of dementia. Cholinesterase inhibitors modestly improve a broad range of symptoms in some patients with Alzheimer's disease through enhancement of cholinergic neurotransmission. These drugs may also be . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |